| Company Name: |
Alfa Chemistry |
| Tel: |
1-516-6625404 |
| Email: |
support@alfa-chemistry.com |
12(S)-HETrE manufacturers
- 12(S)-HETrE
-
- $333.00
-
2026-07-27
- CAS:72710-10-2
- Purity:
- Supply Ability: 10g
|
| | 12(S)-HETrE Basic information |
| Product Name: | 12(S)-HETrE | | Synonyms: | 12(S)-HETrE;8,10,14-Eicosatrienoic acid, 12-hydroxy-, (8Z,10E,12S,14Z)-;12(S)-hydroxy-8(Z),10(E),14(Z)-eicosatrienoic acid;12(S)-HETrE(solution in ethanol) | | CAS: | 72710-10-2 | | MF: | C20H34O3 | | MW: | 322.48 | | EINECS: | | | Product Categories: | | | Mol File: | 72710-10-2.mol |  |
| | 12(S)-HETrE Chemical Properties |
| Boiling point | 487.413±33.00 °C(Press: 760.00 Torr)(predicted) | | density | 0.971±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | Store at -20°C | | solubility | 0.1 M Na2CO3: 2 mg/ml; DMF: Miseble; DMSO: Miseble; Ethanol: Miscible; PBS (pH 7.2): 0.8 mg/ml | | pka | 4.772±0.10(predicted) |
| | 12(S)-HETrE Usage And Synthesis |
| Description | 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).1 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 μM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.1 | | Uses | 12(S)-HETrE is a fatty acid metabolite that inhibits platelet aggregation. 12(S)-HETrE can be used in thrombosis-related research[1]. | | Definition | ChEBI: 12(S)-HETrE is a HETrE that is (8Z,10E,14Z)-icosatrienoic acid in which the hydroxy group is located at the 12(S)-posiiton. It has a role as a human xenobiotic metabolite. It is functionally related to an all-cis-icosa-8,11,14-trienoic acid. It is a conjugate acid of a 12(S)-HETrE(1-). | | References | 1. Ikei, K.N., Yeung, J., Apopa, P.L., et al. Investigations of human platelet-type 12-lipoxygenase: Role of lipoxygenase products in platelet activation J. Lipid Res. 53(12),2546-2559(2012). |
| | 12(S)-HETrE Preparation Products And Raw materials |
|